[HTML][HTML] Significant hypo-responsiveness to GPVI and CLEC-2 agonists in pre-term and full-term neonatal platelets and following immune thrombocytopenia

AT Hardy, V Palma-Barqueros… - Thrombosis and …, 2018 - thieme-connect.com
AT Hardy, V Palma-Barqueros, SK Watson, JD Malcor, JA Eble, EE Gardiner, JE Blanco…
Thrombosis and haemostasis, 2018thieme-connect.com
Neonatal platelets are hypo-reactive to the tyrosine kinase-linked receptor agonist collagen.
Here, we have investigated whether the hypo-responsiveness is related to altered levels of
glycoprotein VI (GPVI) and integrin α2β1, or to defects in downstream signalling events by
comparison to platelet activation by C-type lectin-like receptor 2 (CLEC-2). GPVI and CLEC-
2 activate a Src-and Syk-dependent signalling pathway upstream of phospholipase C (PLC)
γ2. Phosphorylation of a conserved YxxL sequence known as a (hemi) immunotyrosine …
Neonatal platelets are hypo-reactive to the tyrosine kinase-linked receptor agonist collagen. Here, we have investigated whether the hypo-responsiveness is related to altered levels of glycoprotein VI (GPVI) and integrin α2β1, or to defects in downstream signalling events by comparison to platelet activation by C-type lectin-like receptor 2 (CLEC-2). GPVI and CLEC-2 activate a Src- and Syk-dependent signalling pathway upstream of phospholipase C (PLC) γ2. Phosphorylation of a conserved YxxL sequence known as a (hemi) immunotyrosine-based-activation-motif (ITAM) in both receptors is critical for Syk activation. Platelets from human pre-term and full-term neonates display mildly reduced expression of GPVI and CLEC-2, as well as integrin αIIbβ3, accounted for at the transcriptional level. They are also hypo-responsive to the two ITAM receptors, as shown by measurement of integrin αIIbβ3 activation, P-selectin expression and Syk and PLCγ2 phosphorylation. Mouse platelets are also hypo-responsive to GPVI and CLEC-2 from late gestation to 2 weeks of age, as determined by measurement of integrin αIIbβ3 activation. In contrast, the response to G protein-coupled receptor agonists was only mildly reduced and in some cases not altered in neonatal platelets of both species. A reduction in response to GPVI and CLEC-2, but not protease-activated receptor 4 (PAR-4) peptide, was also observed in adult mouse platelets following immune thrombocytopenia, whereas receptor expression was not impaired. Our results demonstrate developmental differences in platelet responsiveness to GPVI and CLEC-2, and also following immune platelet depletion leading to reduced Syk activation. The rapid generation of platelets during development or following platelet depletion is achieved at the expense of signalling by ITAM-coupled receptors.
Thieme Connect